Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress.

Szczegóły
Comments

Tytuł:: Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress.
Autorzy:: Henningfield JE; PinneyAssociates and The Johns Hopkins University School of Medicine, 4800 Montgomery Lane, Suite 400, Bethesda, MD, 20184, USA. .
Fields S; Department of Psychological & Brain Sciences, Texas A&M University, 4235 TAMU, College Station, TX, 77843, USA.
Anthony JC; Michigan State University, College of Human Medicine, 909 Wilson Road Room B601, East Lansing, MI, 48824, USA.
Brown LS Jr; START Treatment & Recovery Centers, 22 Chapel Street, Brooklyn, NY, 11201, USA.
Bolaños-Guzmán CA; Department of Psychological & Brain Sciences, Texas A&M University, 4235 TAMU, College Station, TX, 77843, USA.
Comer SD; Columbia University Irving Medical Center and the New York State Psychiatric Institute, 1051 Riverside Drive #120, New York, NY, 10032, USA.
De La Garza R 2nd; University of New Mexico Health Sciences Center, College of Pharmacy, Albuquerque, NM, 87131, USA.
Furr-Holden D; Michigan State University, College of Human Medicine, 200 E First St., Flint, MI, 48503, USA.
Garcia-Romeu A; The Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA.
Hatsukami DK; University of Minnesota Medical School and Masonic Cancer Center, 717 Delaware St SE, Minneapolis, MN, 55414, USA.
Raznahan A; National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD, 20892, USA.
Zarate CA; National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD, 20892, USA.
Źródło:: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Apr; Vol. 46 (5), pp. 871-876. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: 2003- : London : Nature Publishing Group
Original Publication: [New York, NY] : Elsevier, [c1987-
MeSH Terms:: Neuropharmacology*
Psychopharmacology*
Educational Status ; Humans ; United States ; Universities
References:: J Infect Dis. 2019 Aug 20;220(220 Suppl 2):S33-S41. (PMID: 31430380)
Am Psychol. 2019 Nov;74(8):898-911. (PMID: 31697126)
JAMA. 2015 Sep 15;314(11):1175-7. (PMID: 26372589)
Neuropsychopharmacology. 2016 Sep;41(10):2421-3. (PMID: 27510298)
Science. 2016 Feb 5;351(6273):564-5. (PMID: 26912690)
Am J Public Health. 2003 Feb;93(2):272-6. (PMID: 12554583)
Soc Stud Sci. 2011 Feb;41(1):5-30. (PMID: 21553638)
Nat Genet. 2004 Nov;36(11 Suppl):S13-5. (PMID: 15507997)
Sci Am. 2014 Oct;311(4):44-5. (PMID: 25314870)
Hugo J. 2011 Dec;5(1-4):47-63. (PMID: 22276086)
BMC Genet. 2017 Nov 28;18(1):99. (PMID: 29179688)
JAMA. 2018 Oct 16;320(15):1533-1534. (PMID: 30264136)
Nat Hum Behav. 2018 Oct;2(10):726-734. (PMID: 31406295)
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12240-2. (PMID: 26392553)
Acad Med. 2016 Aug;91(8):1098-107. (PMID: 27306969)
Am Psychol. 2019 Feb-Mar;74(2):232-244. (PMID: 30762387)
Science. 2011 Aug 19;333(6045):1015-9. (PMID: 21852498)
Entry Date(s):: Date Created: 20200804 Date Completed: 20210623 Latest Revision: 20240402
Update Code:: 20240402
PubMed Central ID:: PMC8115073
DOI:: 10.1038/s41386-020-0784-y
PMID:: 32746445
: Czasopismo naukowe

Comment in: Neuropsychopharmacology. 2021 Apr;46(5):877. (PMID: 33219312)
Comment in: Neuropsychopharmacology. 2021 Apr;46(5):880-881. (PMID: 33514874)
Comment in: Neuropsychopharmacology. 2021 Apr;46(5):878-879. (PMID: 33558676)

Informacja